RxY (part of the P/S/L Group) is a Global Healthcare Research business focused on understanding the real reasons behind treatment selection. Founded in 2018, RxY is dedicated to helping our clients understand which therapies are considered for a patient, what drives the actual treatment decision, and why therapies were not considered.
Focusing on “in-play” patients, i.e., newly-initiating or switching, RxY provides unique insights and recommendations to drive clients’ patient share.
RxY utilizes AI and chatbot technology to deliver precise understanding of “in the moment” decision making by physicians.
Via our analytics teams, RxY provides deep analysis supporting: senior executives, competitor intelligence, brand & insights teams.
Deliverables include, but are not limited to: reports, presentations, workshops, and dashboards.
To discuss how RxY can address your unmet, business-critical needs, please contact us: https://www.rxyhc.com/#ContactUs
Company Details
- Employees
- 20
- Address
- 1140 6th Ave #14, New York,new York 10036,united States
- Industry
- Market Research
- NAICS
-
Marketing Research and Public Opinion Polling
- Website
- https://www.rxyhc.com/
- Keywords
- Atopic Dermatitis, Psoriasis, Psoriatic Arthritis, Crohn's Disease, Ulcerative Colitis, Multiple Sclerosis, Type 2 Diabetes, COPD, United States, France, Germany, Italy, Spain, United Kingdom, Austria, Belgium, Netherlands, Switzerland, Japan, Canada, China, Canada, Rheumatoid Arthritis, Migraine, Multiple Myeloma, Chronic Lymphocytic Leukemia, Asthma, Atopic Dermatitis.
- HQ
- New York, New York
Rxy Questions
Rxy's website is https://www.rxyhc.com/
Rxy's LinkedIn profile is https://www.linkedin.com/company/rxy
Rxy has
20 employees.
View email and phone details for 20
employees at Rxy.
Rxy's industry is
Market Research
Rxy's top competitors are
Firstword Group,
Peerdirect,
Spherix Global Insights,
Icr Surveys,
Stethos,
Peervoice,
Medefield,
Sermo,
Psl Group,
Instar Research.
Rxy's categories are Market Research
